Viewing Study NCT00004935


Ignite Creation Date: 2025-12-24 @ 10:42 PM
Ignite Modification Date: 2025-12-25 @ 8:12 PM
Study NCT ID: NCT00004935
Status: TERMINATED
Last Update Posted: 2023-04-18
First Post: 2000-03-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2
Sponsor: Swiss Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module